Tristel (LON:TSTL)‘s stock had its “corporate” rating restated by equities researchers at FinnCap in a report released on Monday.

Shares of LON:TSTL opened at GBX 232.50 ($3.04) on Monday. Tristel has a 12-month low of GBX 175.56 ($2.29) and a 12-month high of GBX 326.01 ($4.26).

In related news, insider Paul Christopher Swinney bought 8,300 shares of the business’s stock in a transaction that occurred on Monday, November 19th. The shares were bought at an average price of GBX 235 ($3.07) per share, with a total value of £19,505 ($25,486.74).

About Tristel

Tristel plc develops, manufactures, and markets infection control, contamination control, and hygiene products in the United Kingdom, Germany, and internationally. It offers hospital infection prevention and control products under the Tristel brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand.

Further Reading: Trading Strategy Methods and Types

Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with's FREE daily email newsletter.